Original Research
Accepted on 29 Sep 2025
Modelling Lymphocyte Subset Dynamics after Ublituximab therapy in patients with Multiple Sclerosis: An Italian Prospective Study
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 29 Sep 2025
in Multiple Sclerosis and Neuroimmunology
Review
Accepted on 25 Sep 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 25 Sep 2025
in Multiple Sclerosis and Neuroimmunology
Mini Review
Published on 25 Sep 2025
in Multiple Sclerosis and Neuroimmunology
Systematic Review
Accepted on 23 Sep 2025
in Multiple Sclerosis and Neuroimmunology
Perspective
Accepted on 23 Sep 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 23 Sep 2025
in Multiple Sclerosis and Neuroimmunology
Editorial
Accepted on 22 Sep 2025
in Multiple Sclerosis and Neuroimmunology
Systematic Review
Accepted on 22 Sep 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 19 Sep 2025
in Multiple Sclerosis and Neuroimmunology
Editorial
Published on 18 Sep 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 18 Sep 2025
in Multiple Sclerosis and Neuroimmunology
Review
Accepted on 17 Sep 2025
in Multiple Sclerosis and Neuroimmunology
Review
Accepted on 16 Sep 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 15 Sep 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 15 Sep 2025
in Multiple Sclerosis and Neuroimmunology